NanoMaxx ultrasound award finalist

Intravenous products: SonoSite, Inc., announced today that the 6 lb. NanoMaxx™ ultrasound system was Read more

Safe Place IV device

Intravenous products: JarrowAndHebburnGazette.com report “A South Tyneside electronics company is helping Read more

Infusion safety implementation

Intravenous products: Hospira, Inc., a leading provider of clinical information and medication delivery Read more

Infusion safety system

Intravenous products: OneMedPlace.com report “Intravenous (IV) drugs leave a huge margin for human Read more

IV catheterization patent

Intravenous products: News-Medical.net “Acacia Research Corporation announced today that a subsidiary has Read more

Hospira pharmaceutical acquisition

Hospira, Inc., and Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, today announced

Read more

Pre-filled catheter lock syringe

Intravenous products: News-Medical.net report “Excelsior Medical Corporation, one of the leading manufacturers Read more

Q-Syte Nexiva recall extended

Intravenous products: BD has voluntarily executed a product recall of certain lots of BD Q-Syte™ Luer Access Devices Read more

StickSafe injection tray

Intravenous products: Dexigner.com report “According to NHS experts, an ingenious new device will not only Read more

Prion and leukocyte filter

Intravenous products: News-Medical.net report “Pall Corporation, a global leader in filtration, separation and purification, Read more

Intra-dermal syringe

Intravenous products: Olberon Medical Innovation, a medical start up company based in Nottingham UK, have Read more

Posiflush pre-filled saline

Intravenous products: BD Saline is changing name to BD PosiFlush. BD PosiFlush is a range of ready to use sterile pre-filled Read more

WHIN® Safe Huber needle launched

Intravenous products: PRnewswire report “B. Braun Medical Inc. (B. Braun) has launched its new safe and easy-to-use WHIN® Read more

Passive safety intravenous catheter

Intravenous products: NewsMedical.net report “MedPro Safety Products, Inc. (OTCBB: MPSP), a leading developer Read more

Innovative intravenous (IV) pump

Intravenous products: nzherald.co.nz report “An innovative intravenous system is set to open up an export flow for medical manufacturers Read more

New owners for VeinViewer

Intravenous products: ocbj.com report “Christie Digital Systems Inc. of Cypress said Wednesday it bought the assets of Luminetx Read more

Safe intravenous (IV) administration

Intravenous products: Medscape.com report “At the American Society of Health-System Pharmacists (ASHP) 44th Midyear Clinical Read more

USB blood glucose meter

Intravenous products: MedGadget.com report “Bayer has recently released the CONTOUR USB blood glucose meter that plugs directly into a Read more

Cannula pack video

Intravenous products: In March 2009, Healthexec TV featured a case study that demonstrated how Vygon (UK) Ltd has worked Read more

Zingo assets sold

Intravenous products: PR-Canada.net report “Anesiva, Inc. announced today that on December 3, 2009, Anesiva entered into an Asset Read more

Safety IV cannula patent issue

Intravenous products: PHARMABIZ.com report “Poly Medicure Ltd., an India-based manufacturer and exporter of safety IV Read more

Power-injectable Apheresis catheter

Intravenous products: PRweb.com report “r4 Vascular, a Minnesota-based medical device company best known for its Pegasus™, Zeus™, and Read more

IV port and Huber needle supplier

Intravenous products: The French company Perouse Medical, known under Laboratoires Perouse for more than 15 years, has decided to enter Read more

IV preparation area

Intravenous products: Derby’s hospitals have been short-listed for the National Patient Safety Award for safeguarding Read more

First IV stick assistance

Intravenous products: Olberon Medical Innovation will be receiving a development grant for it’s ‘Patent Pending’ Cannula Read more

CJD blood filter

Intravenous news: The BBC report “Children under 13 undergoing a blood transfusion should be given specially filtered blood to Read more

Digital pen tracks glucose levels

Intravenous products: Medgadget report “Keeping track of blood glucose levels over time without a computer can be a challenge Read more

Vygon Timestrip top ten listing

Intravenous products: Hot on the heels of its double prize-winning scoop at the UK Packaging Awards, Timestrip has now had a product Read more

VanishPoint infringement verdict

Intravenous products: Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, announced today that a Read more

Emergency IV drip control

Intravenous products: When paramedics rush to the scene of a multi-car pileup or a terror attack, their first task is to assess who needs Read more

Prefillable medical syringe

Medical technology company Becton Dickinson (BD) is preparing to launch trial production runs at a new €100m syringe Read more

PCA pump birthday

Intravenous products: News-Medical.net report “Today Hospira, Inc. (NYSE: HSP) celebrates the 25th anniversary of its market- Read more

Timestrip IV adopted by NHS Trust

Intravenous products (entry updated 29th October 2009): Timestrip Plc is delighted to announce that Walton Centre NHS Read more

Syringe safety label

Intravenous products: News-Medical.net report “iMDsoft®, a global leader in clinical information systems for perioperative, critical, Read more

ChloraPrep Showcase Hospital report

Intravenous products: Showcase Hospitals report number 4 on ChloraPrep® 2% Chlorhexidine Gluconate w/v 70% Isopropyl Alcohol Read more

New IV catheter invented

Intravenous products: TheDartmouth.com report: “A new intravenous catheter insertion system designed by Dartmouth Read more

IV safety UK deal

Intravenous products: ProactiveInvestor.com.au report “Australian-based medical products manufacturer and distributor BMDI TUTA Read more

Accuvein in Greece, Spain and Portugal

Intravenous products: AccuVein LLC today announced a five-year agreement with the Ferrer Group, a leading international Read more

Tegaderm CHG IV securement dressing

IV products: 3M Health Care has announced the launch of its newest infection prevention product in the UK, Tegaderm CHG Read more

NanoMaxx ultrasound system launched

Intravenous products: SonoSite, Inc. specialist in hand-carried ultrasound for the point-of-care, announced Read more

CareFusion IV pump alert

Intravenous products: CareFusion is alerting healthcare professionals about a number of safety problems with several models Read more

Hospira IV pump alert

Hospira, Inc. has issued an alert about a number of the company’s medical devices that have defective AC Read more

IV luer disinfection cap

Intravenous products: Excelsior Medical, one of the leading manufacturers of pre-filled catheter flush syringes and syringe pump Read more

Voice assisted IV documentation

Intravenous products: Informationweek.com report “Butler Memorial Hospital recently completed a pilot project where three IV Read more

Phlebotomy robot

Intravenous products: Mwdgadget.com report “Here is a project from the folks at the Department of Mechanical Engineering at Read more

NxStage System One launched in UK

Intravenous products: Inside-Hospitals.co.uk report “The Lister Hospital in Stevenage, part of East and North Read more

IV site skin disinfection

Intravenous products: IVTEAM are pleased to announce the publication of our third sponsored product page. This Read more

IV pump connectivity

Intravenous products: News-Medical.net report “Arcomed AG, a global provider of IV pumps, and Capsule, the leading provider of Read more

Wireless insulin pump

Intravenous products: MedGadget.com report “Medtronic has released a new insulin pump/continuous glucose monitoring system, called Read more

Insulin pump alert from FDA

Intravenous products: FDA report “In July, Medtronic recalled certain infusion sets which are used with the company’s Mini-Med Paradigm insulin pumps to deliver insulin to diabetic patients. Because of a manufacturing error, the vents on these sets may clog and then fail to equalize the air pressure in the reservoir compartment with the surrounding atmosphere. If this happens, the pump could deliver too much or too little insulin to the patient, and that could lead to serious injury or death.”

Click here for the full report.

Safety IV device demand grows

Intravenous products: InfectionControlToday.com report “A new market research report, “U.S. Infection Prevention Products & Services,” from Reportlinker.com projects that the total demand for infection prevention products and services will increase 4.5 percent annually through 2013. Growth will partially reflect the impact of new government legislation and changing health insurance reimbursement policies aimed at reducing the incidence of healthcare-acquired infections (HAIs). Gains will also be driven by efforts to reduce the incidence of HAIs in healthcare and life science institutions, prompting upgrades to standards involving patient and staff hygiene and protection, facility cleaning and disinfection, device and instrument sterilization and medical waste collection and disposal.

According to the report, safety-enhanced devices for IV and injectable drug delivery and in vivo fluid withdrawal, along with high-quality apparel, textiles and disinfectants for surgical procedures, will remain the top selling groups of infection prevention products. An increasing percentage of the syringes, catheters, IV administration sets, blood collection supplies and other disposable sharp instruments employed by the medical community will incorporate safety components designed to prevent accidental needlesticks and associated infections after use.”

Click here for the full story.

IV safety catheters

Intravenous products: IVTEAM welcome the publication of our second sponsored product page. This particular page is dedicated to safety IV catheters. You will find product information, a useful cannula insertion video, corporate information and contacts.

Click here to visit the product page.

IRadimed MRI IV pump FDA clearance

IRadimed announces 510K Clearance of the New Non Magnetic MRidium MRI IV Pump with Integrated Masimo SET SpO2 Monitoring

Intravenous products: The United States Food and Drug Administration has granted IRadimed Corporation clearance of its new MRidium 3860+ MRI Infusion System with integrated Masimo SET SpO2 Monitoring. Transport to the MRI for Sedation, Critical Care, and Cardiac Patients to date has required multiple pieces of equipment, with hospital infusion pumps and SpO2 being typically not designed to be integrated and functional in the MRI. Clinicians no longer have to remember each time when they get to the door of the MRI to remove their standard hospital SpO2 equipment so that it does not become a dangerous projectile, or risk a patient burn, in the MR environment. IRadimed has innovatively combined two critically needed technologies for the MRI to increase productivity, patient safety, and ease of transport to, from, and within, the MRI.

The Innovative MRidium 3860+ MRI Infusion System is the first Non Magnetic IV Pump designed specifically for use in the MRI Environment with Integrated Masimo SET technology. “We chose the Masimo SET technology because it has such an excellent reputation in the marketplace. “Masimo’s systems are viewed by most as one of the best monitoring technologies in the world.” said Todd Weber, VP Sales and Marketing. Safety in the MR is the primary concern when it comes to meeting needs for required patient care. These risks are all well known, as essential IV and monitoring equipment can: fly into the bore, cause artifacts on the images, become un-reliable during crucial deliveries of medications and monitoring, or shut down completely when needed the most. Use of improper pulse oximeters has caused severe burns to patients due to the high RF fields involved within MR scanners. “It is critical to have products which have been designed with the utmost care and thorough insight of this harsh and potentially dangerous environment,” said Roger Susi, founder of IRadimed Corporation.

Click here for the full press release.

ChloraPrep® video with David Mitchell

Intravenous products: Enturia, makers of ChloraPrep®, the 2% chlorhexidine gluconate in 70% isopropyl alcohol skin antisepsis system have produced a fun animation (with the voice of David Mitchell) that examines the skin.

Closed needlefree connector

Intravenous products: IVTEAM are pleased to bring you the first of a number of sponsored product pages. This particular page is dedicated to closed needlefree connectors. You will find video of the products and a number of studies related to the devices in question.

Click here to visit the product page.

Biopatch CHG update

Intravenous products: FoxBusiness.com report that “Ethicon Inc., a  Johnson & Johnson Company, today announced that BIOPATCH((R)) Protective Disk with CHG (chlorhexidine gluconate) will include new design elements and updated packaging to make it easier for surgeons, nurses and other healthcare providers to apply the product correctly around catheters to reduce the risk of catheter-related bloodstream infections (CRBSIs). Distribution of BIOPATCH((R)) with the enhanced design and packaging began on August 10, 2009 and the product will be available nationwide by mid-August.

The enhanced design and packaging for BIOPATCH((R)) includes easy-to-follow instructions and clearly marked “up” arrows to signify correct application with respect to skin orientation of the product. This new design is intended to provide clear and immediate guidance on the application of BIOPATCH((R)) with each use. In addition, BIOPATCH((R)) packaging now features color-coded elements designed to instantly identify the size and center-hole diameter of the product.”

Click here to view the full press release.

AccuVein vein viewer gains CE mark

Intravenous products: AccuVein LLC, maker of the AV300, the world’s first hand-held, non-contact vein illumination device,  announced today that its medical device now carries a CE Mark, enabling the Company to commence European sales of AccuVein’s AV300.

“Receiving approval to ship the AV300 to Europe is an important step in bringing this beneficial device to healthcare practitioners around the globe,” said Stephen P. Conlon, President of AccuVein. “Furthermore, Europe provides a significant growth opportunity for AccuVein allowing us to build upon our successful launch in the United States.”

Click here for the full press release.

// –>
// –>
// –>
// –>
// –>
// –>
// –>
// –>
// –>
// –>
// –>
// –>
// –>

Antimicrobial needlefree connector

Intravenous products: ICU Medical describe the new antimicrobial needlefree device. On the ICU Medical website they state “The new Antimicrobial CLAVE is the only antimicrobial connector with dedicated internal fluid path technology. The same features that make the CLAVE the least likely to transmit bacteria over any other brand, now has the added feature of an antimicrobial additive.

CLAVE is the only connector which has been proven to reduce intraluminal catheter colonization in a randomized clinical trial. The reversed, split-septum technology and dedicated internal fluid path are the heart of what makes the CLAVE least likely to transmit bacteria than any other brand.

ICU Medical developed the Antimicrobial CLAVE to enhance the dedicated internal fluid path and further reduce the risk of bacterial ingress into the catheter. Ionic silver has been infused into all fluid path contact components which includes the internal cannula and split septum seal.”

Click here to view more information on the ICU Medical website.

BD Nexiva closed IV update

Intravenous products: PRNewsWire.co.uk report “BD Medical, a segment of BD (Becton, Dickinson and Company), announced today the UK launch of the latest BD Nexiva(TM) Closed IV Catheter System designed to reduce healthcare workers’ risk of needlestick injuries and minimise exposure to blood. The system includes the BD Q-SyteTM Luer Access Split Septum to help reduce catheter-related bloodstream infections (CRBSIs).

The new version of the BD Nexiva(TM) system introduces key developments, including:

• New non-removable pinch clamp for easy, one-handed activation
• Soft stabilisation platform designed to decrease catheter movement and associated complications, whilst providing greater patient comfort
• New catheter grip design which accommodates the various insertion techniques employed by clinicians
• Larger bore extension tubing on 18G and 20G cannulas for improved flow rates”

Click here for the full press release.

Peripheral IV dwell-time indicator

Intravenous products: Timestrip.com report “Timestrip’s newly-launched Timestrip I.V. product has achieved positive feedback from its recent trials at the Whittington Hospital in London, at the same time as the company has announced the appointment of a UK distributor for the product. Timestrip I.V. is designed to enable quick assessment of how long an intravenous cannula has been in place, ensuring hospitals comply with infection control procedures. Existing policy directives stipulate that Peripheral Intravenous Cannulae (PVCs) must be changed every 72 hours.

The Whittington introduced Timestrip I.V. to a pilot medical ward between 1st May and 13th June, during which routine inspection of Timestrip I.V. was incorporated into the Trust’s existing cannula inspection policy. During the trial period, the ward maintained a 100% compliance rate with the inspection policy and positive feedback was received from nursing staff and patients alike about the information offered by Timestrip I.V.. The Trust believes that nursing time could be saved by using Timestrip I.V., avoiding the need for staff to compile and refer to written records. The trial concluded that co-locating Timestrip I.V. with the cannula would offer the greatest benefits, allowing both the cannulated site and the Timestrip I.V. display to be checked in a single observation.

In the meantime, Timestrip has appointed Vygon (UK) Ltd as its main distributor for Timestrip I.V. products in the UK and Ireland. Vygon is a leading supplier of single-use medical and surgical products, including intravenous access devices, to the NHS. In the UK alone there are over 40 million venepuncture and cannulation procedures a year and Vygon will make Timestrip I.V. available to hospitals through the NHS Supply Chain from the end of July”.

Click here for the full press release.

For more product information email caroline.redmond@vygon.co.uk

Intravenous drug mixing robot

Intravenous products: MedGadget.com report “Intelligent Hospital Systems, a company out of Winnipeg, Canada, has developed a robotic system for precise preparation of syringes and IV bags for busy hospital pharmacies. We discovered the Robotic IV Automation (RIVA) device when we read the announcement of the firm receiving the 21st Century Achievement Award from the Computerworld Honors Program”.

Click here for the full story.

ICU Medical profit growth

Intravenous products: The Wall Street Journal report “ICU Medical Inc.’s (ICUI) second-quarter profit grew by 20% as demand for the company’s disposable medical products was stable despite the economic downturn. The company also raised its full-year earnings, revenue and margins targets, due to improvements in its existing businesses as well as its acquisition of Hospira Inc.’s (HSP) critical-care product line, which is expected to close in the third quarter. The $35 million acquisition is expected to add 1 cent to 2 cents a share in the second half of the year”.

Click here for the full story.

MicroEye blood biosensor

Intravenous products: Reported on theengineer.co.uk “Doctors could continuously monitor the characteristics of a critically ill patient’s blood using a new device being developed in the UK.

The MicroEye, from Bedfordshire-based Probe Scientific, would fit inside traditional IV catheters inserted into the veins of intensive-care patients. The device incorporates a semi-permeable membrane, which sits in the vein of a patient, and a biosensor located outside the body to measure blood characteristics such as glucose, potassium and urea levels.

The technology, which is still under development, recently received £1m worth of venture capital funding to bring it closer to commercialisation.

Click here for the full story.

TimestripIV distributed by Vygon

Intravenous products: ProcativeInvestors.co.uk report “Timestrip PLC said it appointed Vygon (UK) Ltd as the main distributor for TimestripIV products in the United Kingdom and Ireland. TimestripIV is a technology that enables clinicians and patients to quickly assess how long a cannula has been in place and thus take appropriate action in line with hospital infection control procedures.

TimestripIV will be available to hospitals through the NHS supply chain from the end of July. Vygon also intends to include TimestripIV as a component in a new cannulation pack that will be available in the coming months.

Click here for the full story.

FDA insulin pump alert

Intravenous products: The July FDA Patient Safety News Alert describes that “Disetronic Medical Systems is notifying healthcare professionals and patients about a possible defect with the some of the company’s ACCU-CHEK Spirit insulin pumps. The defect can cause the “up” and “down” buttons on these pumps to stop working, either completely or intermittently. These buttons are used to change the pump programming or to administer additional insulin through a bolus delivery. So if they do not work, pump users may not be able to change any of the pump’s programmed settings.

When the buttons are pushed, the pump normally responds with a confirmation signal: a sound, a vibration, or both. If the buttons stop working, the signal will not occur, and the pump display will not change. If pump users cannot confirm that a change was made, they should disconnect the pump and switch to a back-up pump or other insulin delivery method. Then they should immediately contact the company’s hotline to get a replacement pump. If the buttons on the pump continue to work, the company says the pumps can still be used, but users should make sure the “up” and “down” buttons are working, by verifying that they get a confirmation signal after each pump operation”.

For more information call the ACCU-CHEK Spirit hotline. That number is 1-800-778-5095.

Click here for the full FDA alert.

Novel PICC coating

Intravenous products: News-Medical.net report “A novel coating being used on a new peripherally inserted central catheter (PICC) from r4 Vascular mimics the cell layer found on natural tissue surfaces.

r4 Vascular designed the catheter to have a biomimetic surface that mimics the natural glycocalyx layer on endothelial tissues. Laboratory tests prove that mimicking the glycocalyx layer can dramatically reduce thrombus formation on the catheter surfaces. r4 Vascular recently gained FDA clearance to launch their first catheter based on this Biomimetic technology. It will be available beginning June 30, 2009 as the Zeus Coated CT PICC”.

Click here for the full item.

Needlefree injection FDA approval

Intravenous products: MedGadget.com report “The FDA issued approval for Antares Pharma’s (Ewing, New Jersey) needle-free injection device for use with Tev-Tropin brand human growth hormone (hGH) from Teva out of Petach Tikva, Israel. The device will be marketed under the name Tev-Tropin Tjet Injector system”.

Teva will market the Antares needle-free device as the Tev-Tropin Tjet Injector system.

“We are pleased to add this new technology to our growing portfolio through our successful partnership with Antares, and to offer patients a less invasive delivery system,” stated Larry Downey, head of Teva`s North America Brand Pharmaceuticals division. “This significant achievement demonstrates our ability to leverage our leadership in the pharmaceutical industry, and our ongoing commitment to utilize our global strengths in innovative activities.”

Click here for the story on MedGadget.

Click here for the full press release.

Peripheral IV placement study

Intravenous products: GetTheWordOut.com report “University Hospitals Case Medical Center has been selected by Telesso Technologies Limited, a global healthcare company, as the second site to enroll patients in a head-to-head trial evaluating its FDA-approved guide wire-assisted peripheral IV catheter versus the industry’s gold standard device for peripheral IV placement.

A peripheral vein is the most common site for insertion of a catheter for short-term diagnostic or therapeutic use. The catheter is placed into the peripheral vein in the arm, below the elbow and is typically passed up inside the vein to a length of 2-3 inches.

Telesso’s uniquely-designed guide wire-assisted peripheral IV catheter device uses a retractable guide wire system that is believed to enable easier IV access, reduce common safety risks, significantly lessen patient pain and discomfort, and provide cost savings to facilities by lowering administrative costs associated with failed IV starts”.

Click here for the full story.

IV ultrasound support on iPhone

Intravenous products: The SonoAccess™ application is your direct link to SonoSite. They have designed this medical iPhone® app to give you helpful resources such as videos that demonstrate techniques for specific scanning procedures, quick guides for reimbursement information, and more.

At the tap of a finger, a portable, on-demand library of high quality clinical and system instructional videos, case studies, clinical image gallery and reference guides on point-of-care ultrasound applications is available to any medical professional or student.

SonoAccess™ for the iPhone™ is available downloadable for free from iTunes – click here to download

IV containers and pumps win award

Intravenous products: InfectionControlToday.com report “Medical Device and Diagnostic Industry magazine has recognized three medical devices manufactured by B. Braun Medical Inc. as being among the most influential medical devices of the last 30 years. B. Braun’s Outlook® Safety Infusion System, PINNACLE® TPN Management System and EXCEL® and PAB® IV Containers were all recognized in the magazine’s 30 Years, 30 Devices special commemorative issue”.

“It truly is a great honor that B. Braun has contributed to the industry’s advancement in infusion therapy,” said Eric Steen, senior vice president and chief marketing officer for B. Braun Medical Inc. “In developing these and all other B. Braun products, we continuously seek innovative ways to translate our customer’s needs into products with unmatched quality, cost-effectiveness, environmental responsibility and safety.”

Click here for the full story.

Sonosite ultrasound remote

Intravenous products: “SonoSite, Inc. the world leader and specialist in hand-carried ultrasound for point-of-care medicine, announced today that it has begun customer shipments of the SonoRemote™ Control, a compact voice or touch activated solution for adjusting ultrasound controls at a distance when using SonoSite M-Turbo® or S Series™ systems.

Approximately the size of an iPhone® and using Bluetooth® technology, the SonoRemote Control is capable of adjusting essential system parameters – Depth, Gain, Freeze and Save – within 10 meters of the ultrasound system. With voice activation or when used in a sterile sheath, the SonoSite remote control eliminates the need to break the sterile field during interventional procedures. And with a tactile reference keypad the user does not have to look at the remote to identify which button to press—even the touchpad has been designed with increased workflow in mind”.

Click here for the full press release.

Detecting intravenous infiltration

Intravenous products: Matthew Alley (CW Optics, Inc) has submitted a poster recently presented at the Infusion Nurses Society 2009 annual meeting.

Abstract:

Intravenous infiltration is a serious problem associated with infusion therapy.  It is usually accompanied by pain, erythema, and swelling at the needle insertion site.  Severe infiltration may lead to necrosis requiring skin debridement, skin grafting, and/or amputation.  Early detection of infiltration prevents the occurrence of serious incidents.  A new device, ivWatch™, was developed to monitor the intravenous infusion site for infiltration.  The results of validation studies on animal and human subjects are presented.  A clinical trial on 800 patients is currently underway to investigate safety and efficacy of the ivWatch™.

Click here to view the poster.

Intravenous (IV) drip rate calculator

Intravenous products: Drug Infusion: An IV Med Drip Rate Calculator App by iAnesthesia LLC on for the iPhone iTunes.

Drug infusion was designed specifically for the ICU nurse or anesthesia provider as a quick reference to ensure accurate calculations for dose, concentration or IV rate.

Designed by anesthesiologists, this IV Med Drip Rate Calculator is quick and easy to use in point-of-care environments.

Click here to view the Apps page on iTunes.

More IV news at IVTEAM

IV pole redesigned

Intravenous products: Core77.com report “Every research project is a journey. This one started in Basingstoke, England, a small city 50 miles southwest of London in a hospital run by the National Health Service. I was there for Modo to think about IV poles—an ordinary piece of healthcare furniture. Modo researches, designs and builds carts and trolleys for medical devices and customers like Herman Miller, Steelcase and Philips. This project was for Cardinal Health, a $60 billion company”.

Click here for the full story.

More IV news at IVTEAM

AccuVein locate hard-to-find veins

Intravenous products: AccuVein LLC today announced the launch of AccuVein AV300, the world’s first hand-held, non-contact vein illumination device that helps healthcare professionals locate hard-to-find veins. IV starts and blood draws (venipuncture) can be a source of patient anxiety and discomfort, and accessing veins in difficult patients can take up to 10 minutes and require multiple needle sticks.

Venipuncture is the most common invasive medical procedure with an estimated 2.7 million procedures conducted every day in the United States alone. The AV300 can help reduce the need for multiple needle sticks, with the goal of improving patient care and the time to access veins.

Product video shown below:

 

Click here for the full press release.

More IV news at IVTEAM

Vascular access training phantom

Intravenous products: CIRS is pleased to introduce the Model 072 Vascular Access Training Phantom Kit. The Model 072 was designed to provide a realistic training medium for needle insertion.  It is made from a durable elastometric compound mimicking the tactile feel and puncture resistance of soft tissue.  This self-healing material has realistic acoustic properties allowing imaging of the simulated palpable vessels under ultrasound. The phantom includes one bifurcated vessel and 2 straight walled vessels at a variety of depths and diameters to simulate a range of challenges often encountered in the clinical environment. The phantom can be easily replenished without leakage using a syringe (included) and a stopcock enables increased vessel pressure for more realistic simulation.  The kit also includes needles and a supply of simulated blood.  The phantom requires no special handling and will not dry out.

Click here for the full press release.

US contact admin@cirsinc.com

UK contact phil@imagingequipment.co.uk

More IV news at IVTEAM

Cook’s new Spectrum Turbo-Ject PICC

With the launch of Cook Medical’s new Spectrum Turbo-Ject PICC, for the first time, the clinical benefits of antibiotic-impregnated catheters—a critical component in eliminating 250,000 potentially fatal catheter-related bloodstream infections (CRBSIs) in the U.S. annually—are now available for peripherally inserted central venous catheters (PICCs) that can also be used for contrast-enhanced CT scans.

The Spectrum Turbo-Ject PICC is the industry’s first antibiotic-impregnated PICC capable of accepting the contrast media injection rates required for CT scans. The ability to power-inject contrast media, combined with the Spectrum technology’s proven ability to prevent CRBSIs, means that patients receiving PICC lines will gain the highest possible protection from deadly CRBSIs, while clinicians will have access to the industry’s best flow rates.

“Cook’s new Spectrum Turbo-Ject PICC lines provide industry-leading technology to interventional radiologists, nurses and other health care professionals in the fight against costly, life-threatening hospital-acquired infections, and also provide industry-best flow rates for contrast media,” said Dan Sirota, global business leader of Cook Medical’s Interventional Radiology division. “This innovation further demonstrates Cook’s commitment to reducing infections by providing a unique Cook technology that is proven to improve patient outcomes.”

Demand for the new PICC is so high, he added, that the first units were shipped to customers even before Cook’s official introduction of the device to key customers at the Society of Interventional Radiology Meeting earlier this year in San Diego.

With the Spectrum Turbo-Ject PICC, clinicians can choose from multiple catheter configurations that offer an industry-best range of flow rates in order to meet patient needs, including:

• Maximum pressure limit settings of 325 psi
• 5 French single and double lumen with a maximum flow rate of 7 and 5 mL/second, respectively
• 4 French single lumen with a maximum flow rate of 4 mL/second
• 50 cm and 60 cm length available

Click here for the full press release.

More IV news at IVTEAM

Timestrip IV hospital order

Intravenous products: TradingMarkets.com report ‘Timestrip PLC, a UK-based smart label company, declared on 5 May that the company has secured an order with Luton & Dunstable Hospital, which has become the second hospital to place an order for the newly launched TimestripIV product, designed to help hospitals comply with existing policy directives that stipulate the need to change Peripheral Intravenous Cannulae (PVCs) every three days, as part of infection control protocols”.

Click here for the full news item.

More IV news at IVTEAM

Baxter buy stake in Sigma IV pump

Intravenous products: Forbes.com report ‘Baxter International Inc. said Wednesday it bought a stake in Sigma International and will market one of the company’s infusion pumps, paying $100 million upfront in the deal.

Baxter will buy a 40 percent stake in Sigma of Medina, N.Y., and could pay an additional $130 million if the Spectrum pumps reach development, regulatory and commercial milestones, or buy the company outright. The deal is not expected to have a significant impact on Baxter’s results this year”.

Click here for the full story on Forbes.com

More IV news at IVTEAM

TimestripIV

Intravenous products: SmallCapNews.co.uk report “Smart label company Timestrip has agreed a partnership deal with hospital supplies business Brenmoor Ltd that will see it introduce a new product to Brenmoor’s range of printable patient wristbands that are used widely within the NHS. This is the second product in the newly launched TimestripMedical range. Timestrip and Brenmoor have developed a detachable clip with fully integrated TimestripIV technology, which will be attached directly onto the clasp of the Brenmoor wristband. The process of attaching the clip to the wristband will also activate the TimestripIV.

TimestripIV has been designed to help hospitals comply with existing policy directives that stipulate the need to change Peripheral Intravenous Cannulae (PVCs) every 72 hours. The company announced the launch of TimestripIV on last week alongside an order from the Whittington Hospital to allow them to undertake an in-use assessment of the product.

Click here for the full story on SmallCapNews.co.uk

More IV news at IVTEAM

Pulse oximetry detects fluid volume

Intravenous products: Masimo the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low-Perfusion pulse oximetry, today announce that a new clinical study, independently conducted by researchers from the University of California-San Francisco (UCSF), demonstrates that Masimo PVI accurately and reliably reflects acute changes in intravascular fluid volume (preload). The study, presented at the International Anesthesia Research Society (IARS) 83rd Scientific Congress on March 14th in San Diego, Calif., affirms PVI as a highly predictive indicator of patient fluid status.

Assessing whether a patient needs fluid to increase their cardiac index (amount of blood the heart pumps each minute) is one of the biggest challenges anesthesiologists face during surgery. Although fluid administration is critical to optimizing patient status and enabling end organ preservation, unnecessary fluid administration is associated with increased morbidity and mortality and traditional invasive measurements are only 50 to 60% accurate at predicting improvement in cardiac index after volume administration. PVI—a new method for noninvasive and automatic assessment of fluid responsiveness—has been shown in multiple studies to predict fluid responsiveness in mechanically ventilated patients, helping clinicians to optimize fluid administration and improve patient outcomes.

In the study, Errol P. Lobo, M.D., PhD, at UCSF in San Francisco, Calif., and colleagues used Masimo Radical-7 Pulse CO-Oximeters to noninvasively measure and continuously track PVI, perfusion index (PI) and pulse rate (PR) data during 16 consecutive liver transplant operations. Researchers extracted and analyzed the noninvasive data at three critical points where preload changes occur rapidly: 1) immediately before clamping, 2) during clamping, and 3) immediately after clamping of the inferior vena cava (IVC), and found that PVI changed rapidly and significantly in response to known acute changes in preload (clamping and unclamping of IVC) in 100% of the cases.

Click here for the full press release.

More IV news at IVTEAM

IV Station from Health Robotics

Intravenous products: PharmacyEurope.net report that a “US medical technology firm has unveiled a robot designed to deliver accurate and efficient intravenous (IV) mixtures to patients in a safe and cost effective way. The IV Station from Health Robotics can automatically mix compounds while producing ready to administer IV doses in a variety of syringes, bags, vials, and tamper-evident caps.

The launch at the European Association of Hospital Pharmacists, in Barcelona, Spain, was also accompanied by a display of the company’s CytoCare, a pioneering chemotherapy IV robot.

Health Robotics said the new IV device was designed to minimise medication errors, and address high costs, lack of sterility and difficulties in maintaining adequate and trained staff. The firm has already reached agreements for the delivery of 16 IV Stations to medical facilities in countries across the globe, including the UK, Japan, Turkey and Italy”.

Click here for the full story on PharmacyEurope.net

More IV news at IVTEAM

TauroLock catheter lock solution

Intravenous products: The Peninsula (Qatar) has reported on TauroLock, an anti-microbial catheter lock solution that prevents catheter-related bloodstream infections in dialysis, oncology and parenteral nutrition, got the nod of the Infection Control Department of the Hamad Medical Corporation and the Al Amal Hospital.

“We got a positive response from the oncology department of the Hamad and Al Amal hospitals… and the Infection Control Department of Hamad has endorsed the product,” said Prof Dr Claus Herdeis, managing director of the German company TauroPharm.

Herdeis said TauroLock, which was introduced in the European market in 2004 and was just brought in to Doha, is a solution placed in catheters to prevent infection.

Click here for the full news story on thepeninsularqatar.com

More IV news at IVTEAM

Baxter IV pump alert

Intravenous products: Baxter International Inc. has found more problems with its long-troubled “Colleague” intravenous fluid pumps, including software glitches the company needs to fix and user problems it has advised customers to avoid.

The Deerfield, Ill., company sent a letter to customers on Jan. 23, a day after its fourth-quarter earnings call, to highlight the newfound issues with its entire roster of 275,000 Colleague pumps around the world, including pumps the company issued during remediation efforts to fix other problems. Colleague pumps were first pulled in 2005 amid a host of problems and defects linked to some deaths.

The latest problems came under the spotlight Wednesday when Baxter said the U.S. Food and Drug Administration had assigned a “Class 1″ recall status to the matter, which is the agency’s most serious recall classification.

Click here to view the full news item on CNNMoney.com

More IV news at IVTEAM

Alaris IV pump alert

Intravenous products: This Safety Alert informs you about a potential risk when the Alaris® PCA module (model 8120) is used with the Alaris® PC Unit (model 8000 and model 8015) with software versions 8 through 9.1. The Alaris® PCA module can potentially infuse above or below the intended infusion dose.

Click here to view the full safety notice.

More IV news at IVTEAM

Vacuette safety needle system

Intravenous products: MedPro Safety Products Inc. is undergoing safety testing for a product known as the Vacuette Premium Safety Needle System, a self-capping needle used for drawing blood. The goal of the system is to eliminate accidental sticks with a used needle by eliminating any chance of human error.

Walter Weller, president and chief operating officer of MedPro, said he thinks Vacuette Premium Safety needles have several aspects that make them stand out from existing blood collection systems.
The first is what he describes as “passive” technology — that is, the needle cover deploys on its own. “What’s unique about it is that we don’t require interaction from the phlebotomist. We don’t ask them to push buttons or snap clips,” Weller said. Weller estimates that 35 percent of needle-stick injuries occur from the time the needle leaves the arm to transportation to a container or destructive device.
Click here for the full story on Kentucky.com
More IV news at IVTEAM

Needlestick reduction

Intravenous products: A Sheffield-based healthcare company, B Braun Medical, is helping to prevent needlestick injuries to NHS staff. The company’s patented safety device, which eliminates the risk of being accidentally stuck or scratched by needles when delivering medication through a cannula, has already been snapped up by more than 70 UK NHS trusts.

And those who have adopted the technology say they are cutting down on injuries as a result. At Manchester Royal Infirmary, for example, there was an average of 19 needlestick injuries every year, but there have been none since the introduction of the Vasofix and Introcan safety devices.

Click here for the full press release.

More IV news at IVTEAM

Alteplase dosing error

Intravenous products: The FDA state that in a recent report, the Institute for Safe Medication Practices warned about the possibility of prescribing and administering the wrong dose of alteplase when the indication for the drug is not specified.

ISMP described a case of a patient in an interventional radiology department who suffered respiratory arrest from a pulmonary embolism. The physician in charge of the radiology procedure called a code and requested Activase 100 mg IV. The pharmacist who responded to the code called the IV admixture staff and asked for tPA, or tissue plasminogen activator, a synonym for alteplase.

Because the call came from the radiology department, and because the prescribed dose and the intended use were not communicated, the pharmacy staff did not realize that the drug was intended to treat a pulmonary embolus. Instead, they assumed that the alteplase was intended to restore catheter function, so instead of the 100 mg dose that had been prescribed, they dispensed 2 mg of alteplase. 

The physician running the code assumed the syringe he received contained the correct dose and administered it, which gave the patient a 50-fold underdose. The patient died, although it’s not clear what impact, if any, the medication error had on his death.

Click here for the full alert.

More IV news at IVTEAM

Baxa acquired ForHealth Tech

Intravenous products: Baxa Corp., involved in packaging and administering medications, said Tuesday it has acquired ForHealth Technologies, Inc., a Florida-based healthcare robotics and software company. Englewood-based Baxa said the acquisition is “a strategic expansion of its focus on health-system pharmacy automation and IV-room productivity.” Terms were not disclosed. The deal brings to Baxa the pharmacy management products IntelliFill i.v. and IntelliFlowRx, devices that automate the preparation of intravenous medications.

Click here for full news story.

More IV news at IVTEAM

Gemstar infusion system

Intravenous products: Hospira, Inc., a global specialty pharmaceutical and medication delivery company, today announced the  introduction of the with GemStar(TM) Infusion Suite software, an advanced version of the market-leading, multi-application, GemStar pump. The GemStar SP infusion system is designed to help caregivers better incorporate patient safety best practices right at the patient’s bedside.

GemStar SP incorporates GemStar Infusion Suite software, a stand-alone personal computer (PC)-based application designed to enhance safe and efficient medication administration. In an effort to help clinicians combat the 1.5 million medication errors that occur annually(1), GemStar SP allows healthcare facilities to tailor the pump to meet specific clinical objectives.

The compact and portable pump has configurable settings to help streamline the programming process for clinicians and provide flexible drug protocols with hard limits to help prevent medication errors. GemStar also offers several security features including four keypad lockouts, integral set-based free flow protection and mandatory confirmation screens, to help minimize the risk of medication delivery errors.

Click here for the full press release.

More IV news at IVTEAM

Triple lumen PICC

Intravenous products: Teleflex Medical, a division of Teleflex Incorporated, has introduced the Arrow® Pressure Injectable Triple Lumen PICC (Peripherally Inserted Central Catheter), the latest in the company’s portfolio of venous access solutions designed for clinician and patient safety, as well as patient comfort. With a non-tapered body, contoured tip and strong polyurethane construction that softens in situ, Arrow PICCs are designed to improve vessel health preservation and reduce the risk of thrombosis and infection associated with venous catheters.

The Arrow Pressure Injectable Triple Lumen PICC provides the ability to pressure-inject contrast media, clear and useful product labeling, a non-tapered catheter body, and the unique Arrow Blue FlexTip®, which is a contoured design for smooth maneuverability through narrow vessels. The Blue FlexTip is designed to reduce patients’ vessel trauma. The catheter’s firmness also maintains patency throughout treatment, as it withstands high-pressure injection procedures. This unique tip design, with its staggered ports, is designed to reduce the risk of medications mixing and forming a precipitate that could obstruct other trimmed catheters. The Arrow Pressure Injectable Triple Lumen PICC is also indicated for central venous pressure monitoring.

It is capable of pressure injection of contrast media at 300 psi and a maximum flow rate of six milliliters per second. The improved catheter polymer is designed to have clear visualization under fluoroscopy and other radiographic studies.

The Arrow Pressure Injectable Triple Lumen PICC will be available in the U.S. as part of the Arrow Maximal Barrier Tray, which is an integrated kit designed to address sources of catheter-related bloodstream infection, specifically environmental contamination and skin flora. The Arrow Maximal Barrier Tray also includes prefilled saline syringes, BIOPATCH® Antimicrobial Dressing, Tegaderm® Transparent Dressing, protective apparel and upgraded sharps safety devices. Its components are aligned with the latest guidelines from the Centers for Disease Control (CDC), the Occupational Safety & Health Administration (OSHA) and the Institute for Healthcare Improvement (IHI).

Click here for the full press release.

More IV news at IVTEAM

Rev Vac safety syringe FDA approval

Intravenous products: Revolutions Medical Corporation (OTCBB: RMCP) has received notification from the FDA that the 510K application for the Rev Vac safety syringe is approved. This represents a major step forward for the company towards realizing its goal in becoming a major player in the safety syringe market.

The Rev Vac safety syringe uses patented technology to draw the needle back into the syringe chamber after use. This safety syringe should result in a decrease in accidental needle stick injuries. Another important safety feature is that it will disallow the reuse of the syringe. This may significantly decrease the spread of HIV and other blood borne diseases. This safety syringe takes only one hand to use, which is a very important feature for the health care practitioner or medical personnel. There are no clumsy clamps, sheaths or other complex safety features that require two handed use.

“We are pleased to receive 510K FDA clearance for our Rev Vac safety syringe. I want to congratulate all of our patient, loyal shareholders. This important step forward will enable the company to aggressively pursue its goal of getting this important safety syringe into the marketplace. Our Rev Vac safety syringe has significant advantages over our competitors and we expect a warm reception from the medical industry,” states Ron Wheet, CEO of Revolutions Medical Corporation.

Click here for the full story.

Click here to view the product video.

More IV news at IVTEAM

Reuse of sharps containers

Intravenous products: A recent survey on use and reuse of sharps containers by Novation, Irving, Texas, asked members of its two owner groups, VHA and University Health System Consortium (UHC), their views on the topic. The survey, released in late October 2008, showed 60 percent of materials managers, nurses, risk managers and other hospital officials consider reusable sharps containers to be safe, a major increase over Novation’s 2006 survey, when only 38 percent of respondents thought so.

This article first appeared in the January 2009 issue of Materials Management in Health Care.

Click here for the full story.

More IV news at IVTEAM

Enteralok prevents IV errors

Intravenous products: A new range of enteral syringes has been launched by Sheffield based InterVene® Ltd. In recent years, numerous deaths have occurred by administering enteral medication via intravenous (IV) lines. The enteral syringe which was designed in UK, has been produced in response to National Patient Safety Agency (NPSA) guidelines aimed at preventing maladministration of enteral medication via IV routes. 

The syringe employs a ‘reverse luer’ or ‘female luer’ tip which cannot be interchanged with a conventional IV syringe. A purple plunger immediately identifies the syringe as an enteral device and the words ‘Enteral / Oral’ are clearly displayed on the barrel.

Click here for the full press release.

Click here to visit the Enteralok website.

More IV news at IVTEAM

CareFusion® formed by Cardinal

Cardinal Health, a global provider of products and services that improve the safety and productivity of healthcare, has selected a name for the medical technology company that will be formed through the proposed spin-off of its clinical and medical products businesses.

The new company will be named CareFusion®, reflecting a diverse blend of medical technologies the company will offer to improve the safety and quality of care. From infusion and medication safety technologies to respiratory equipment, automated medical supply dispensing and infection prevention offerings, CareFusion® will be the largest medical technology company with a singular focus on patient safety. The new company expects to trade on the New York Stock Exchange under the ticker symbol CFN.

Click here for the full story.

More IV news at IVTEAM

// –> // –> // –>

VeinViewer in Australia

Intravenous products: One Sydney hospital is among the first in Australia to trial a revolutionary machine that lets clinicians see the veins mapped out on the surface of the skin, reducing the number of failed attempts at cannulation.

The VeinViewer, which will be tested in the hematology unit at Royal Prince Alfred Hospital, displays infra-red images on the skin of the underlying veins. The light shows up the hemoglobin in red blood cells and the image is captured by video camera. The images are processed by a computer and projected onto the patient’s skin using a green light.

The machine, which costs about $50,000, can detect veins six millimetres beneath the skin surface or in the scalp beneath hair and was named by Time magazine as being one of the best medical inventions of 2004.

Click here for the full story.

More IV news at IVTEAM

Safety syringe deal

Intravenous products: Inviro Medical Devices, an industry leader in infection control products, has recently been awarded a three-year contract with Novation, one of the nation’s largest and most respected GPOs, or group provider organizations. As Novation members represent 20% of the nation’s community hospitals and clinics, Inviro now has a greater opportunity to market its manually retractable safety syringe products to a wider medical and health care audience. Inviro’s partnership with the GPO, which began on February 01, 2009, also underscores the high level of quality all Novation product contracts must possess.

Click here to view the full press release.

More IV news at IVTEAM

Cathflo buyout

Intravenous products: Roche has announced that it is commencing a cash tender offer for all outstanding publicly-held shares of Genentech for US$86.50 per share.

Genentech are the manufacturers of Cathflo® Activase® (Alteplase) which is indicated for the restoration of function to central venous access devices (CVADs) as assessed by the ability to withdraw blood.

Click here for the full news story.

More IV news at IVTEAM

Sonix ultrasound obtains CE Mark

Intravenous products: Ultrasonix Medical Corporation, a leading developer and manufacturer of high quality diagnostic ultrasound imaging systems announced today that it has received the CE Mark for the SonixTOUCH ultrasound imaging system.

SonixTOUCH is a, compact, portable diagnostic ultrasound system developed around Ultrasonix’s next generation OpenSONIX platform. The SonixTOUCH is capable of generating premium-level image quality with a completely touch-screen-driven reconfigurable user interface. The system can be configured for virtually any ultrasound application and use model, making it the world’s first truly market-adaptable ultrasound system. The SonixTOUCH received FDA (510k) clearance in November 2008 with shipments beginning in December.

Click here for the full press release.

More IV news at IVTEAM

Safe Point device award

Intravenous products: A needle safety product emerged victorious at the third annual Banbury Innovation Award. Steve Cooley, a 43-year-old dentist from Adderbury, took home the prize after impressing the Dragons’ Den-style judging panel with his Safe Point needle remover. 

The device, which Mr Cooley envisages becoming, at the least, a part of every dentist’s surgery in the UK, safely removes used surgical needles from a syringe, avoiding the current risk of getting a ‘needle stick’ cut by doing it manually. 

Click here for the full story.

More IV news at IVTEAM

Next Page »